Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 453-454

  Biasi, Domenico ^a,b   Bambara, Lisa Maria ^a   Carletto, Antonio ^a   Casaril, Massimo ^a   Capra, Franco ^a   Caramaschi, Paola ^a   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

Fibrogenesis; Lam; Methotrexate; NPIIIP; Rheumatoid arthritis

Indexed keywords

LAMININ; METHOTREXATE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FIBROSIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; LAMININ; LIVER CIRRHOSIS; MALE; METHOTREXATE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 0029937793     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Whitmg-O'Keefe QE, Fye KH. Sack KD: Methotrexate and histologic hepatic abnormalities: A meta-analysis. Am J Med 1991;90.711-6.
2. Bjorkman DJ, Boschert M, Tolman KG, Clegg DO, Ward JR: The effect of long term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis. Arthritis Rheum 1993;36:1697-701.
3. Bjorkman DJ, Hammond EH, Lee RG, Clegg DO, Tolman KG: Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 1988;31:1465-72.
4. Gabrielli GB, Corrocher R: Hepatic fibrosis and its serum markers: A review. Dig Dis 1991;9-303-16.
5. Capra F, Casaril M, Gabrielli GB, et al.: α-Interferon in the treatment of chronic viral hepatitis: Effects on fibrogenesis serum markers. J Hepatol 1993;18:112-8.
6. Trinchet JC: Clinical use of serum markers of fibrosis in chronic hepatitis. J Hepatol 1995;(suppl 2)22:89-95.
7. Horslev-Petersen K, Bentsen KD, Halberg P, et al.: Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 1988;6:129-34.
8. Eberhardt K, Thorbjorn Jensen L, Horslev-Petersen K, Pettersson H, Lorenzen I, Wollheim F: Serum aminoterminal type III procollagen peptide in early rheumatoid arthritis. Relation to disease activity and progression of joint damage. Clin Exp Rheumatol 1990;8:335-40.
9. Tamaro G, Danek GM, Mangiarotti MA, et al.: Methotrexate therapy and liver fibrosis: Are human prolyl hydroxylase and type IV collagen reliable and sensitive markers? (letter). Int J Clin Lab Res 1995;25:55.
10. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.